2m 2m 2m 2m 2m 2m 2m
CORMEDIX (CRMD)
NASDAQ
$8.28+$0.11 (+1.29%)
Price as of Jun 03, 2026 6:08 PM EDT- $662.1MMarket Cap
- -35.21%1-Year Change
- BiotechnologyIndustry
CORMEDIX (CRMD)
$8.28+$0.11 (+1.29%)
CRMD | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $8.17 | ||
Change | -$0.28 (-3.31%) | ||
Open | $8.40 | ||
High | $8.41 | ||
Low | $8.10 | ||
Previous Close | $8.45 | ||
Volume | 964,191 | ||
30-Day Average Volume | 1,415,815 | ||
1-Week Change | -1.21% | ||
1-Month Change | 4.88% | ||
1-Year Change | -35.21% | ||
3-Year Change | 58.95% | ||
5-Year Change | 10.55% | ||
Fundamentals | |||
Shares Outstanding | 78.5M | ||
Total Assets | $815.6M | ||
Market Cap | $662.1M | ||
Enterprise Value | $484.0M | ||
Period: QTR TTM FY | |||
Revenue | $121.9M | ||
Net Income | $38.6M | ||
Free Cash Flow | $41.7M | ||
EBIT | $55.6M | ||
EBITDA | $66.2M | ||
Net Working Capital | $254.3M | ||
EPS | $0.43 | ||
Enterprise Value/EBITDA | 7 | ||
Enterprise Value/Revenue | 4 | ||
P/B | 2 | ||
P/E | 20 | ||
PEG | 0 | ||
Price/Free Cash Flow | 16 | ||
Price/Operating Cash Flow | 16 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 5 | ||
Last Split Date | 03/26/2019 | ||
Earnings & Revenue